IL18BP and metabolic dysfunction-associated steatotic liver disease: In contrast, on HFHC and CDAHFD diets, classically used to induce MASLD/MASH in rodents, we observed that Il18bp−/− mice present worsened hepatic inflammation compared with WT mice, suggesting that IL-18BP represents an important gatekeeper of liver integrity during MASLD/MASH.